Home › Compare › ULIHF vs JNJ

ULIHF vs JNJ: Dividend Comparison 2026

ULIHF yields 4.61% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ULIHF wins by $3914.36M in total portfolio value
10 years
ULIHF
ULIHF
● Live price
4.61%
Share price
$1.30
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3914.38M
Annual income
$3,757,849,931.79
Full ULIHF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ULIHF vs JNJ

📍 ULIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodULIHFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ULIHF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ULIHF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIHF
Annual income on $10K today (after 15% tax)
$392.01/yr
After 10yr DRIP, annual income (after tax)
$3,194,172,442.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ULIHF beats the other by $3,194,171,738.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIHF + JNJ for your $10,000?

ULIHF: 50%JNJ: 50%
100% JNJ50/50100% ULIHF
Portfolio after 10yr
$1957.20M
Annual income
$1,878,925,379.79/yr
Blended yield
96.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ULIHF
No analyst data
Altman Z
2.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIHF buys
0
JNJ buys
0
No recent congressional trades found for ULIHF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricULIHFJNJ
Forward yield4.61% ✓3.36%
Annual dividend / share$0.06$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR100% ✓5.8%
Portfolio after 10y$3914.38M ✓$20.0K
Annual income after 10y$3,757,849,931.79 ✓$827.78
Total dividends collected$3903.33M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ULIHF vs JNJ ($10,000, DRIP)

YearULIHF PortfolioULIHF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,622$922.37$10,676$355.77+$946.00 → ULIHF
2$14,440$2,003.76$11,407$389.39+$3.0K → ULIHF
3$20,104$4,653.23$12,198$426.53+$7.9K → ULIHF
4$33,620$12,109.28$13,056$467.62+$20.6K → ULIHF
5$73,826$37,852.07$13,987$513.12+$59.8K → ULIHF
6$234,355$155,361.26$14,998$563.56+$219.4K → ULIHF
7$1,172,599$921,838.97$16,098$619.52+$1.16M → ULIHF
8$9,876,061$8,621,381.00$17,295$681.69+$9.86M → ULIHF
9$146,291,644$135,724,258.55$18,599$750.82+$146.27M → ULIHF
10$3,914,381,991$3,757,849,931.79$20,022$827.78+$3914.36M → ULIHF

ULIHF vs JNJ: Complete Analysis 2026

ULIHF — Stock

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Full ULIHF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ULIHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIHF vs SCHDULIHF vs JEPIULIHF vs OULIHF vs KOULIHF vs MAINULIHF vs ABBVULIHF vs MRKULIHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.